Table 1.
Defined molecular structures activating inflammasome pathways
Inflammasome | Stimulus | Reference |
---|---|---|
NLRP1 | Anthrax lethal toxin | [6] |
MDP | [32] | |
NLRP3 | Pore-forming agents | |
Listerolysin O | [64] | |
Streptolysin | [136] | |
Nigericin | [64] | |
Maitotoxin | [137] | |
Saponin | [116] | |
Hemolysins | [138] | |
Ion channels or their activators | ||
P2X7/ATP | [64] | |
Influenza virus M2 channel protein | [70] | |
Phagocytosed materials (crystals, crystalline material, particles, protein aggregates) | ||
Monosodium uric acid crystals | [73] | |
Asbestos fibers | [76] | |
Silica | [75, 76] | |
Aluminum salts | [75, 78, 116] | |
Hemozoin crystals | [80, 82] | |
Cholesterol crystals | [99] | |
Poly lactide-co-glycolide and polystyrene microparticles | [139] | |
Amyloid beta | [84] | |
Hyaluronan | [140] | |
NLRC4 | Flagellin | [7] |
Components of the T3SS | [57] | |
AIM2 | Double-stranded DNA | [10–13, 130, 131] |
For clarity, only studies that have reported a molecularly defined activating signal in a loss-of-function or knock-out experiment for the respective inflammasome component were considered. In this regard, NLRP3-activating signals that are only defined for their priming component (signal I) but not their activating component (signal II) are not listed